SK Life Science, Inc.
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2002-01-01
- Employees
- 101
- Market Cap
- -
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
- First Posted Date
- 2013-11-20
- Last Posted Date
- 2014-12-19
- Lead Sponsor
- SK Life Science, Inc.
- Target Recruit Count
- 334
- Registration Number
- NCT01989234
- Locations
- 🇺🇸
Digestive and Liver Disease Specialists, Norfolk, Virginia, United States
🇺🇸Columbus Clinical Research Inc., Columbus, Ohio, United States
🇺🇸Clinical Trials Research Services, LLC, Pittsburgh, Pennsylvania, United States
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
- First Posted Date
- 2013-05-31
- Last Posted Date
- 2022-04-29
- Lead Sponsor
- SK Life Science, Inc.
- Target Recruit Count
- 437
- Registration Number
- NCT01866111
- Locations
- 🇺🇸
Clinical Trials, Inc., Little Rock, Arkansas, United States
🇺🇸Bradenton Research Center, Inc., Bradenton, Florida, United States
🇺🇸Lovelace Scientific Resources, Inc., Sarasota, Florida, United States
A Phase 2 Study to Evaluate Pharmacodynamics of YKP10811 in Patients With Chronic or Functional Constipation
- Conditions
- Interventions
- First Posted Date
- 2012-02-01
- Last Posted Date
- 2014-07-04
- Lead Sponsor
- SK Life Science, Inc.
- Target Recruit Count
- 57
- Registration Number
- NCT01523184
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study for the Pain of Diabetic Peripheral Neuropathy
- First Posted Date
- 2012-01-30
- Last Posted Date
- 2015-06-11
- Lead Sponsor
- SK Life Science, Inc.
- Target Recruit Count
- 128
- Registration Number
- NCT01521598
- Locations
- 🇺🇸
Nerve and Muscle Center of Texas, Houston, Texas, United States
🇺🇸Comprehensive Clinical Development, St. Petersburg, Florida, United States
🇺🇸Clinical Research of West Florida, Inc., Tampa, Florida, United States
Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures
- First Posted Date
- 2011-07-20
- Last Posted Date
- 2022-04-11
- Lead Sponsor
- SK Life Science, Inc.
- Target Recruit Count
- 222
- Registration Number
- NCT01397968
- Locations
- 🇮🇳
Max Super Specialty Hospital, Saket, New Delhi, India
🇵🇱SPSK Nr 7 SUM w Katowicach, Gornoslaskie CM im. Prof. Leszka Gieca, Katowice, Poland
🇺🇸Kaiser Permanente, Anaheim, California, United States
An Open-Label Extension Study to Evaluate the Safety and Tolerability of RWJ 333369 as Adjunctive Therapy in Patients 16 Years and Older With Partial Onset Seizures.
- Conditions
- Interventions
- First Posted Date
- 2009-10-08
- Last Posted Date
- 2013-06-18
- Lead Sponsor
- SK Life Science, Inc.
- Target Recruit Count
- 991
- Registration Number
- NCT00991757
An Efficacy and Safety Study of Carisbamate in the Treatment of Nerve Pain in Diabetics
- Conditions
- Interventions
- First Posted Date
- 2009-03-27
- Last Posted Date
- 2013-01-24
- Lead Sponsor
- SK Life Science, Inc.
- Target Recruit Count
- 386
- Registration Number
- NCT00870454
An Open-Label Extension Study of the Safety and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures
- Conditions
- Interventions
- First Posted Date
- 2008-09-01
- Last Posted Date
- 2013-06-18
- Lead Sponsor
- SK Life Science, Inc.
- Target Recruit Count
- 403
- Registration Number
- NCT00744731
A Study of the Effectiveness, Safety, and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures.
- Conditions
- Interventions
- First Posted Date
- 2008-08-25
- Last Posted Date
- 2013-01-24
- Lead Sponsor
- SK Life Science, Inc.
- Target Recruit Count
- 547
- Registration Number
- NCT00740623
Effectiveness and Safety Study for RWJ-333369 as Adjunctive Therapy in Korean and Japanese Patients With Partial Onset Seizures
- First Posted Date
- 2008-06-16
- Last Posted Date
- 2013-01-23
- Lead Sponsor
- SK Life Science, Inc.
- Target Recruit Count
- 56
- Registration Number
- NCT00697762